文献速递小儿耳鼻咽喉咽喉与嗓音

布洛芬与对乙酰氨基酚比较及儿童扁桃体切除术后严重出血风险:一项非劣效性随机临床试验

Comparison of Ibuprofen vs Acetaminophen and Severe Bleeding Risk After Pediatric Tonsillectomy: A Noninferiority Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2019-01-01

这项多中心、随机、双盲非劣效性试验纳入741例2至18岁接受扁桃体切除术或扁桃体腺样体切除术的儿童,比较术后每6小时使用布洛芬10 mg/kg(n=372)或对乙酰氨基酚15 mg/kg(n=369)共9天对需手术干预的扁桃体切除术后出血的影响。改良意向性治疗分析纳入688例,需手术干预的出血率对乙酰氨基酚组为1.2%、布洛芬组为2.9%(差异1.7%;97.5% CI上限3.8%;非劣效性P=0.12)。研究无法排除布洛芬组严重出血率更高。

要点

  • 布洛芬组需手术干预的出血率为2.9%,对乙酰氨基酚组为1.2%,差异1.7%(97.5% CI上限3.8%)。
  • 非劣效性检验P=0.12,未达到预设的3%非劣效性界值。
  • 研究无法排除布洛芬组严重出血率更高,选择术后镇痛方案时应考虑此发现。

核心结论

  • 本研究无法排除儿童接受布洛芬后扁桃体切除术后严重出血率更高。
  • 选择术后镇痛方案时应考虑此发现。
  • 需进一步研究短期使用布洛芬或与对乙酰氨基酚联用是否影响出血风险。

研究设计与样本

  • 多中心、随机、双盲非劣效性试验,在4家三级医疗中心进行。
  • 共评估1832例儿童资格,排除681例不符合标准及410例拒绝参与,最终纳入741例2至18岁接受扁桃体切除术或扁桃体腺样体切除术的儿童。
  • 纳入时间为2012年5月3日至2017年1月20日。
  • 参与者随机接受布洛芬10 mg/kg(n=372)或对乙酰氨基酚15 mg/kg(n=369),术后前9天每6小时一次。
  • 非劣效性界值设为3%,采用改良意向性治疗分析。

主要发现

  • 741例入组儿童中,688例(92.8%)接受了研究药物并纳入改良意向性治疗分析(中位[四分位距]年龄5[4]岁;366例男孩[53.2%])。
  • 需手术干预的出血率对乙酰氨基酚组为1.2%,布洛芬组为2.9%(差异1.7%;97.5% CI上限3.8%;非劣效性P=0.12)。
  • 未发生显著不良事件或死亡。

关键数值与推荐

  • 主要结局为3型出血(需返回手术室控制出血)。
  • 出血严重程度量表:1型为在家中观察到或在急诊科评估但无需进一步干预的出血;2型为需再入院观察的出血;3型为需返回手术室控制出血。
  • 非劣效性界值为3%。

临床怎么用

  • 原文结论指出,选择术后镇痛方案时应考虑布洛芬组严重出血率可能更高的发现。
  • 原文建议需进一步研究短期使用布洛芬或与对乙酰氨基酚联用是否影响术后出血风险。

局限性

  • 本研究无法排除布洛芬组严重出血率更高。
  • 需进一步研究以了解短期使用布洛芬或与对乙酰氨基酚联用是否影响出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Ibuprofen is an effective analgesic after tonsillectomy alone or tonsillectomy with adenoidectomy, but concerns remain about whether it increases postoperative hemorrhage. OBJECTIVE: To investigate the effect of ibuprofen compared with acetaminophen on posttonsillectomy bleeding (PTB) requiring surgical intervention in children. DESIGN, SETTING, AND PARTICIPANTS: A multicenter, randomized, double-blind noninferiority trial was conducted at 4 tertiary medical centers (Massachusetts Eye and Ear Infirmary, Boston; Naval Medical Center, San Diego, California; Naval Medical Center, Portsmouth, Virginia; Madigan Army Medical Center, Tacoma, Washington). A total of 1832 children were assessed for eligibility (presence of sleep-disordered breathing or obstructive sleep apnea, adenotonsillar hypertrophy, or infectious tonsillitis undergoing extracapsular tonsillectomy by electrocautery). Of these, 1091 were excluded because they did not meet eligibility criteria (n = 681) or refused to participate (n = 410); thus, 741 children aged 2 to 18 years undergoing tonsillectomy alone or tonsillectomy with adenoidectomy were enrolled between May 3, 2012, and January 20, 2017. INTERVENTIONS: Participants were randomized to receive ibuprofen, 10 mg/kg (n = 372), or acetaminophen, 15 mg/kg (n = 369), every 6 hours for the first 9 postoperative days. MAIN OUTCOMES AND MEASURES: Rate and severity of posttonsillectomy bleeding were recorded using a postoperative bleeding severity scale: type 1 (bleeds that were observed at home or evaluated in the emergency department without further intervention), type 2 (bleeds that required readmission for observation), and type 3 (bleeds that required a return to the operating room for control of hemorrhage). Type 3 bleeding was the main outcome measure. The noninferiority margin was set at 3%, and modified intention-to-treat analysis was used. RESULTS: Of the 741 children enrolled, 688 children (92.8%) (median [interquartile range] age, 5 [4] years; 366 boys [53.2%]) received the study medication and were included in a modified intention-to-treat analysis. The rate of bleeding requiring operative intervention was 1.2% in the acetaminophen group and 2.9% in the ibuprofen group (difference, 1.7%; 97.5% CI upper limit, 3.8%; P = .12 for noninferiority). There were no significant adverse events or deaths. CONCLUSIONS AND RELEVANCE: This study could not exclude a higher rate of severe bleeding in children receiving ibuprofen after tonsillectomy alone or tonsillectomy with adenoidectomy. This finding should be considered when selecting a postoperative analgesic regimen. Further studies are needed to understand if bleeding risk is affected when ibuprofen is used for a shorter duration or in combination with acetaminophen for postoperative analgesia. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01605903.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Diercks GR, Comins J, Bennett K, et al. Comparison of Ibuprofen vs Acetaminophen and Severe Bleeding Risk After Pediatric Tonsillectomy: A Noninferiority Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 30946442. doi:10.1001/jamaoto.2019.0269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。